BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Misra R, Patra B, Varadharaj S, Verma RS. Establishing the promising role of novel combination of triple therapeutics delivery using polymeric nanoparticles for Triple negative breast cancer therapy. Bioimpacts 2021;11:199-207. [PMID: 34336608 DOI: 10.34172/bi.2021.27] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
Number Citing Articles
1 Parthiban A, Sachithanandam V, Sarangapany S, Misra R, Muthukrishnan P, Jeyakumar TC, Purvaja R, Ramesh R. Green synthesis of gold nanoparticles using quercetin biomolecule from mangrove plant, Ceriops tagal: Assessment of antiproliferative properties, cellular uptake and DFT studies. Journal of Molecular Structure 2023;1272:134167. [DOI: 10.1016/j.molstruc.2022.134167] [Reference Citation Analysis]
2 Cai L, Xu X, Chen W. The Current State of the Art in PARP Inhibitor-Based Delivery Nanosystems. Pharmaceutics 2022;14:1647. [DOI: 10.3390/pharmaceutics14081647] [Reference Citation Analysis]
3 Anwer MK, Ali EA, Iqbal M, Ahmed MM, Aldawsari MF, Saqr AA, Alalaiwe A, Soliman GA. Development of Chitosan-Coated PLGA-Based Nanoparticles for Improved Oral Olaparib Delivery: In Vitro Characterization, and In Vivo Pharmacokinetic Studies. Processes 2022;10:1329. [DOI: 10.3390/pr10071329] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Vysyaraju NR, Paul M, Ch S, Ghosh B, Biswas S. Olaparib@human serum albumin nanoparticles as sustained drug-releasing tumor-targeting nanomedicine to inhibit growth and metastasis in the mouse model of triple-negative breast cancer. J Drug Target 2022;:1-27. [PMID: 35723068 DOI: 10.1080/1061186X.2022.2092623] [Reference Citation Analysis]
5 Sargazi S, Mukhtar M, Rahdar A, Barani M, Pandey S, Díez-Pascual AM. Active Targeted Nanoparticles for Delivery of Poly(ADP-ribose) Polymerase (PARP) Inhibitors: A Preliminary Review. Int J Mol Sci 2021;22:10319. [PMID: 34638660 DOI: 10.3390/ijms221910319] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 11.0] [Reference Citation Analysis]